182 related articles for article (PubMed ID: 10879740)
41. T- and T/natural killer-cell lymphomas of the salivary gland: a clinicopathologic, immunohistochemical and molecular study of six cases.
Chan JK; Tsang WY; Hui PK; Ng CS; Sin VC; Khan SM; Siu LL
Hum Pathol; 1997 Feb; 28(2):238-45. PubMed ID: 9023409
[TBL] [Abstract][Full Text] [Related]
42. [Nasal/nasopharyngeal T/NK-cell lymphomas with evident angiogenic activity].
Zhang HY; Huang GS; Zhu HT; Zhang YQ; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):317-9. PubMed ID: 12940067
[TBL] [Abstract][Full Text] [Related]
43. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
44. An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features.
Katsaounis P; Alexopoulou A; Dourakis SP; Smyrnidis A; Marinos L; Filiotou A; Archimandritis AJ
Int J Hematol; 2008 Sep; 88(2):202-205. PubMed ID: 18654739
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of nasal T/NK-cell lymphoma among Brazilians.
Altemani A; Barbosa AC; Kulka M; Takahashi T; Endo L; Vassallo J; Lorand-Metze I
Neoplasma; 2002; 49(1):55-60. PubMed ID: 12044062
[TBL] [Abstract][Full Text] [Related]
46. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
Peh SC; Quen QW
Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
[TBL] [Abstract][Full Text] [Related]
47. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study].
Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L
Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124
[TBL] [Abstract][Full Text] [Related]
48. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
Kuo TT; Shih LY; Tsang NM
Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
[TBL] [Abstract][Full Text] [Related]
49. [Expression of cytotoxic-granule-associated protein TIA-1 in nasal NK/T cell lymphomas and lymphoid hyperplasia].
Liu W; Chan AC; Ho FC
Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):247-50. PubMed ID: 11244989
[TBL] [Abstract][Full Text] [Related]
50. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas.
Tsang WY; Chan JK; Ng CS; Pau MY
Am J Surg Pathol; 1996 Feb; 20(2):202-10. PubMed ID: 8554110
[TBL] [Abstract][Full Text] [Related]
51. Comparative ultrastructural study of cytotoxic granules in nasal natural killer cell lymphoma, intestinal T-cell lymphoma, and anaplastic large cell lymphoma.
Sadahira Y; Akisada K; Sugihara T; Hata S; Uehira K; Muraki N; Manabe T
Virchows Arch; 2001 Mar; 438(3):280-8. PubMed ID: 11315625
[TBL] [Abstract][Full Text] [Related]
52. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
53. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
54. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
[TBL] [Abstract][Full Text] [Related]
55. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
56. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
57. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
[TBL] [Abstract][Full Text] [Related]
58. Comparison of primary and secondary cutaneous CD56+ NK/T cell lymphomas.
Chang SE; Yoon GS; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):163-70. PubMed ID: 12051636
[TBL] [Abstract][Full Text] [Related]
59. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia.
Chilosi M; Doglioni C; Yan Z; Lestani M; Menestrina F; Sorio C; Benedetti A; Vinante F; Pizzolo G; Inghirami G
Am J Pathol; 1998 Jan; 152(1):209-17. PubMed ID: 9422538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
